Drug-Coated Balloons in Peripheral Vascular Interventions

doi:N/A

Bangaldesh Journal of Cardivascular Medicine

2025, Volume 3, Issue 3 : 1-6

Research Article

Drug-Coated Balloons in Peripheral Vascular Interventions

Michael R. Anderson

Sarah T. Bennett

Ahmed K. Rahman

Priya Sharma

⁴

David L. Cooper

⁵

Heart Institute of North America, Chicago, USA

Royal Cardiovascular Centre, London, UK

International Medical Research University, Dubai, UAE

⁴

South Asian Heart Institute, New Delhi, India

⁵

Global Cardiovascular Sciences Center, Toronto, Canada

Abstract

Background: Drug-coated balloons (DCBs) have become an important endovascular technology for peripheral artery disease, particularly femoropopliteal disease. They deliver antiproliferative medication to the vessel wall without leaving a permanent implant.

Objective: To review the role, outcomes, advantages, limitations, and future directions of drug-coated balloons in peripheral vascular interventions.

Methods: This narrative review summarizes contemporary clinical evidence, device principles, lesion selection, procedural techniques, safety concerns, and post-procedural management.

Results: DCB therapy improves vessel patency and reduces restenosis compared with plain balloon angioplasty in selected peripheral lesions. Outcomes are strongest in femoropopliteal disease, while evidence continues to evolve for below-the-knee, dialysis access, and complex calcified lesions.

Conclusion: Drug-coated balloons are valuable tools in peripheral vascular intervention, especially when avoiding permanent stent implantation is desirable. Optimal outcomes depend on lesion preparation, appropriate patient selection, and careful follow-up.

Keywords

Drug-coated balloon

Peripheral artery disease

Femoropopliteal intervention

Restenosis

Paclitaxel

Endovascular therapy.

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

Bangladesh J. Cardiovasc. Med. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.

Recommended Articles

Catheter Ablation Outcomes in Persistent Atrial Fibrillation: A Multicenter Prospective Evaluation

Michael R. Anderson,

Sarah L. Thompson,

Ahmed K. Rahman,

Emily J. Foster

1-5

Below-the-Knee Interventions in Diabetic Patients

Michael R. Anderson,

Sarah T. Bennett,

Ahmed K. Rahman,

Priya Sharma,